Acta Chir Orthop Traumatol Cech. 2022; 89(4):266-271 | DOI: 10.55095/achot2022/043

Intramedullary Nailing in Managing Diaphyseal Metastases of Long Bones: Retrospective Study Comparing the Expected Survival and the Actual Survival of PatientsOriginal papers

T. VALOUŠEK*, L. PAZOUREK, T. TOMÁŠ, M. MAHDAL, P. JANÍČEK, V. APOSTOLOPOULOS
I. ortopedická klinika Fakultní nemocnice u sv. Anny v Brně a Lékařské fakulty Masarykovy univerzity, Brno

PURPOSE OF THE STUDY:
The paper focuses on the potential use of nail osteosynthesis in diaphyseal metastases of long bones. The purpose of the paper is to assess the outcomes of intramedullary osteosynthesis in pathologic and impending pathologic fractures, to evaluate patient survival and potential complications.

MATERIAL AND METHODS:
The retrospective study evaluated a cohort of 42 patients (19 men and 23 women) in whom intramedullary osteosynthesis was performed for complete pathologic fracture (28 patients) or impending pathologic fracture (14 patients) between 2010 and 2019. Of the total number of 42 patients, 31 patients' lower limbs were affected, namely by 17 pathologic fractures and 14 impending fractures. There were 11 humerus fractures. The mean age was 61.8 years (range 41-84 years). In the followed-up cohort, the patient survival after osteosynthesis with intramedullary nails, complications occurred and post-operative mobility of the patient were assessed. The functional outcomes were evaluated using the Musculoskeletal Tumor Society (MSTS) scoring system. The unpaired Mann-Whitney test was used to test the significance of the difference in functional outcomes and survival between the followed-up groups. Survival longer than 6 months was evaluated using Fisher's exact test. The level of statistical significance used for the test was p 0.05.

RESULTS:
The investigated indicator was patient survival, which was 11.3 months (range 1-50 months) on average. In the group of impending fractures, the mean survival was 13.5 months. In the group of pathologic fractures, the survival was 10 months. The functional outcome in 16 followed-up patients at three months after intramedullary osteosynthesis according to the MSTS score was 46.9% (30-66.7%). At the level of significance of p 0.05, the statistically significant difference in the functional outcomes between the group with preventive intramedullary osteosynthesis and the group with nail osteosynthesis of the pathologic fracture was not confirmed (p=0.952). When comparing the patient survival after nail osteosynthesis with impending pathologic fracture and the survival of patients with pathologic fracture, a statistically significant difference in survival between these two groups (p=0.520) was not confirmed. The patient survival of longer than 6 months was 71% in the group of impending fractures and 40% in the group of pathologic fractures.

DISCUSSION:
The occurrence of pathologic fracture is associated with increased pain, loss of function, and according to some authors, a higher risk of death. Surgical treatment options include intramedullary osteosynthesis, plate osteosynthesis with cement filling, implantation of an intercalary spacer, and implantation of tumor endoprostheses. When deciding on a surgical procedure, an account is taken of the expected survival of the patient. In patients with an expected survival of up to 6 months, intramedullary osteosynthesis is indicated as a palliative surgical intervention. The most common complications include implant failure and metastatic progression.

CONCLUSIONS:
Intramedullary osteosynthesis is the method of choice in treating pathologic fractures or impending pathologic diaphyseal fractures of long bones in patients with an expected predicted survival of up to 6 months. Intramedullary osteosynthesis aims to reduce pain and enable early verticalization. The study confirmed the importance of preventive intramedullary osteosynthesis and its effect on survival compared to the survival of patients with a pathologic fracture.

Keywords: skeletal metastases, diaphyseal metastases, intramedullary osteosynthesis, pathologic fracture, impending fracture

Published: August 15, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
VALOUŠEK T, PAZOUREK L, TOMÁŠ T, MAHDAL M, JANÍČEK P, APOSTOLOPOULOS V. Intramedullary Nailing in Managing Diaphyseal Metastases of Long Bones: Retrospective Study Comparing the Expected Survival and the Actual Survival of Patients. Acta Chir Orthop Traumatol Cech. 2022;89(4):266-271. doi: 10.55095/achot2022/043. PubMed PMID: 36055666.
Download citation

References

  1. Al-Jahwari A, Schemitsch EH, Wunder JS, Ferguson PC, Zdero R. The biomechanical effect of torsion on humeral shaft repair techniques for completed pathological fractures. J Biomech Eng. 2012;134:024501. Go to original source... Go to PubMed...
  2. Bryson DJ, Wicks L, Ashford RU. The investigation and management of suspected malignant pathological fractures: a review for the general orthopaedic surgeon. Injury. 2015;46:1891-1899. Go to original source... Go to PubMed...
  3. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27:165-176. Go to original source... Go to PubMed...
  4. Damron TA, Sim FH. Surgical treatment for metastatic disease of the pelvis and the proximal end of the femur. Instr Course Lect. 2000;49:461-470. Go to PubMed...
  5. Drost L, Ganesh V, Wan BA, Raman S, Chan S, Christakis M, Tsao M, Barnes E, Ford M, Finkelstein J, Yee A, Turner A, Lam H, Chow E.. Efficacy of postoperative radiation treatment for bone metastases in the extremities. Radiother Oncol. 2017;124:45-48. Go to original source... Go to PubMed...
  6. Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network. PLoS ONE. 2011;6:e19956. Go to original source... Go to PubMed...
  7. Frassica FJ, Frassica DA. Evaluation and treatment of metastases to the humerus. Clin Orthop Relat Res. 2003;415Suppl:S212-218. Go to original source... Go to PubMed...
  8. Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am. 2000;31:515-528. Go to original source... Go to PubMed...
  9. Harvey N, Ahlmann ER, Allison DC, Wang L, Menendez LR. Endoprostheses last longer than intramedullary devices in proximal femur metastases. Clin Orthop Relat Res. 2012;470:684-691. Go to original source... Go to PubMed...
  10. van der Hulst RR, van den Wildenberg FA, Vroemen JP, Greve JW. Intramedullary nailing of (impending) pathologic fractures. J Trauma. 1994;36:211-215. Go to original source... Go to PubMed...
  11. Kinahan PE, Fletcher JW. PET/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31:496-505. Go to original source... Go to PubMed...
  12. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin OrthopRelat Res. 1989;249:256-264. Go to original source...
  13. Moura DL, Alves F, Fonseca R, Freitas J, Casanova J. Treatment of pathological humerus-shaft tumoral fractures with rigid static interlocking intramedullary nail-22 years of experience. Rev Bras Ortop. 2019;54:149-155. Go to original source... Go to PubMed...
  14. Piatek S, Westphal T, Bischoff J, Schubert S, Holmenschlager F, Winckler S. [Intramedullary stabilisation of metastatic fractures of long bones]. Zentralbl Chir. 2003;128:131-138. Go to original source... Go to PubMed...
  15. Pu F, Zhang Z, Wang B, Liu J, Shao Z. En bloc resection and intercalary prosthesis implantation for the treatment of humeral diaphyseal bone metastases. Int Orthop. 2021;45:281-288. Go to original source... Go to PubMed...
  16. Quinn R. Metastatic disease to the hip and pelvis: surgical management. Tech Orthop. 2007;22:78-87. Go to original source...
  17. Ricard M-AM, Stavropoulos NA, Nooh A, Ste-Marie N, Goulding K, Turcotte R. Intramedullary nailing versus plate osteosynthesis for humeral shaft metastatic lesions. Cureus. 2021;13:e13788. Go to original source... Go to PubMed...
  18. Rizzo SE, Kenan S. Pathologic fractures. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2021.
  19. Saad F, Lipton A, Cook R, Chen Y-M, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007;110:1860-1867. Go to original source... Go to PubMed...
  20. Sim FH. Metastatic bone disease of the pelvis and femur. Instr Course Lect. 1992;41:317-327. Go to PubMed...
  21. Tanaka T, Imanishi J, Charoenlap C, Choong PFM. Intramedullary nailing has sufficient durability for metastatic femoral fractures. World J Surg Oncol. 2016;14:80. Go to original source... Go to PubMed...
  22. Ward WG, Spang J, Howe D. Metastatic disease of the femur: surgical management. Orthop Clin North Am. 2000;31:633-645. Go to original source... Go to PubMed...
  23. Weber KL, Randall RL, Grossman S, Parvizi J. Management of lower-extremity bone metastasis. J Bone Joint Surg Am. 2006;88(Suppl 4):11-19. Go to original source... Go to PubMed...
  24. Wedin R, Hansen BH, Laitinen M, Trovik C, Zaikova O, Bergh P, Kalén A, Schwarz-Lausten G, Vult von Steyern F, Walloe A, Keller J, Weiss RJ. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012;21:1049-1055. Go to original source... Go to PubMed...
  25. Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PDS. Treatment of pathological fractures of the long bones. EFORT Open Rev. 2016;1:136-145. Go to original source... Go to PubMed...
  26. Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop Relat Res. 1990;251:213-219. Go to original source...
  27. Yu H-HM, Tsai Y-Y, Hoffe SE. Overview of diagnosis and management of metastatic disease to bone. Cancer Control. 2012;19:84-91. Go to original source... Go to PubMed...